AUA/SUFU成人神经源性下尿路功能障碍指南:诊断与评估
指南强调将患者风险分层为低、中、高或未知风险,并依据风险等级定期监测,新发或加重症状时应重新评估并重复分层。
要点
- NLUTD患者应进行风险分层:低、中、高或未知风险。
- 根据风险等级定期监测,新发或加重症状时重新评估并重复分层。
- 治疗决策需结合尿动力学、认知、手功能、活动能力等多因素共同决策。
核心结论
- NLUTD患者应风险分层为低、中、高或未知风险,并据此定期监测;新发或加重症状时需重新评估并重复分层。
主要发现
- 指南涵盖NLUTD的评估、诊断、风险分层及非手术和手术治疗选择,并包含尿路感染和自主神经反射异常的声明。
- 指南适用于成人NLUTD,不讨论儿童NLUTD。
临床怎么用
- 临床中应对成人NLUTD患者进行风险分层,并按风险等级定期监测,新发或加重症状时重新评估并重复分层。
局限性
- 指南不讨论儿童NLUTD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The clinician treating patients with neurogenic lower urinary tract dysfunction (NLUTD) needs to balance a variety of factors when making treatment decisions. In addition to the patient's urologic symptoms and urodynamic findings, other issues that may influence management options of the lower urinary tract include cognition, hand function, type of neurologic disease, mobility, bowel function/management, and social and caregiver support. This Guideline allows the clinician to understand the options available to treat patients, understand the findings that can be seen in NLUTD, and appreciate which options are best for each individual patient. This allows for decisions to be made with the patient, in a shared decision-making manner, such that the patient's quality of life can be optimized with respect to their bladder management. MATERIALS AND METHODS: A comprehensive search for studies assessing patients undergoing evaluation, surveillance, management, or follow-up for NLUTD was conducted from January 2001 through October 2017 and was rerun in February 2021 to capture newer literature. The primary search returned 20,496 unique citations. Following a title and abstract screen, full texts were obtained for 3,036 studies. During full-text review, studies were primarily excluded for not meeting the PICO criteria. One hundred eight-four primary literature studies met the inclusion criteria and were included in the evidence base. RESULTS: This guideline was developed to inform clinicians on the proper evaluation, diagnosis, and risk stratification of patients with NLUTD and the non-surgical and surgical treatment options available. Additional statements on urinary tract infection and autonomic dysreflexia were developed to guide the clinician. This Guideline is for adult patients with NLUTD and pediatric NLUTD will not be discussed. CONCLUSIONS: NLUTD patients should be risk-stratified as either low-, moderate-, high-, or unknown-risk. After diagnosis and stratification, patients should be monitored according to their level of risk at regular intervals. Patients who experience new or worsening signs and symptoms should be reevaluated and risk stratification should be repeated.
引用
- Ginsberg DA, Boone TB, Cameron AP, et al. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation. J Urol. 2021. PMID: 34495687. doi:10.1097/JU.0000000000002235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。